P. Bories

发表

Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[Chimeric antigen receptor T cells].

L. Ysebaert, P. Bories, L. Ysebaert, 2021, Bulletin du cancer.

Impact of azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes: a study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies.

A. Duhamel, Z. Marjanovic, M. Rubio, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.